These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 27444065)

  • 1. The Emerging Role of Epigenetics in Inflammation and Immunometabolism.
    Raghuraman S; Donkin I; Versteyhe S; Barrès R; Simar D
    Trends Endocrinol Metab; 2016 Nov; 27(11):782-795. PubMed ID: 27444065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent developments on the role of epigenetics in obesity and metabolic disease.
    van Dijk SJ; Tellam RL; Morrison JL; Muhlhausler BS; Molloy PL
    Clin Epigenetics; 2015; 7():66. PubMed ID: 27408648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Reprogramming of the Inflammatory Response in Obesity and Type 2 Diabetes.
    Zatterale F; Raciti GA; Prevenzano I; Leone A; Campitelli M; De Rosa V; Beguinot F; Parrillo L
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetics and Immunometabolism in Diabetes and Aging.
    Guzik TJ; Cosentino F
    Antioxid Redox Signal; 2018 Jul; 29(3):257-274. PubMed ID: 28891325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inflammatory effect of epigenetic factors and modifications in type 2 diabetes.
    Akbari M; Hassan-Zadeh V
    Inflammopharmacology; 2020 Apr; 28(2):345-362. PubMed ID: 31707555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic signatures underlying inflammation: an interplay of nutrition, physical activity, metabolic diseases, and environmental factors for personalized nutrition.
    Ramos-Lopez O; Milagro FI; Riezu-Boj JI; Martinez JA
    Inflamm Res; 2021 Jan; 70(1):29-49. PubMed ID: 33231704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics: spotlight on type 2 diabetes and obesity.
    Desiderio A; Spinelli R; Ciccarelli M; Nigro C; Miele C; Beguinot F; Raciti GA
    J Endocrinol Invest; 2016 Oct; 39(10):1095-103. PubMed ID: 27180180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epigenetics and Life-style diseases].
    Waki H; Yamauchi T; Kadowaki T
    Clin Calcium; 2016 Mar; 26(3):426-32. PubMed ID: 26923981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics and epigenetics in the obesity phenotyping scenario.
    Trang K; Grant SFA
    Rev Endocr Metab Disord; 2023 Oct; 24(5):775-793. PubMed ID: 37032403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of epigenetics in the onset and management of type 2 diabetes mellitus.
    Sommese L; Zullo A; Mancini FP; Fabbricini R; Soricelli A; Napoli C
    Epigenetics; 2017 Jun; 12(6):401-415. PubMed ID: 28059593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic processing in cardiometabolic disease.
    Costantino S; Mohammed SA; Ambrosini S; Paneni F
    Atherosclerosis; 2019 Feb; 281():150-158. PubMed ID: 30290963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell- and tissue-specific epigenetic changes associated with chronic inflammation in insulin resistance and type 2 diabetes mellitus.
    Naidoo V; Naidoo M; Ghai M
    Scand J Immunol; 2018 Dec; 88(6):e12723. PubMed ID: 30589455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic mechanisms in diabetic complications and metabolic memory.
    Reddy MA; Zhang E; Natarajan R
    Diabetologia; 2015 Mar; 58(3):443-55. PubMed ID: 25481708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary factors, epigenetic modifications and obesity outcomes: progresses and perspectives.
    Milagro FI; Mansego ML; De Miguel C; Martínez JA
    Mol Aspects Med; 2013; 34(4):782-812. PubMed ID: 22771541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic disturbances in obesity and diabetes: Epidemiological and functional insights.
    Loh M; Zhou L; Ng HK; Chambers JC
    Mol Metab; 2019 Sep; 27S(Suppl):S33-S41. PubMed ID: 31500829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics and nutrition-related epidemics of metabolic diseases: Current perspectives and challenges.
    Hernández-Aguilera A; Fernández-Arroyo S; Cuyàs E; Luciano-Mateo F; Cabre N; Camps J; Lopez-Miranda J; Menendez JA; Joven J
    Food Chem Toxicol; 2016 Oct; 96():191-204. PubMed ID: 27503834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genetic and epigenetic basis of type 2 diabetes and obesity.
    Drong AW; Lindgren CM; McCarthy MI
    Clin Pharmacol Ther; 2012 Dec; 92(6):707-15. PubMed ID: 23047653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Transcription Factor
    Parrillo L; Spinelli R; Longo M; Zatterale F; Santamaria G; Leone A; Campitelli M; Raciti GA; Beguinot F
    Cells; 2023 Aug; 12(16):. PubMed ID: 37626900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic crosstalk: a molecular language in human metabolic disorders.
    Martinez-Jimenez CP; Sandoval J
    Front Biosci (Schol Ed); 2015 Jun; 7(1):46-57. PubMed ID: 25961686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study.
    Wu YL; Lin ZJ; Li CC; Lin X; Shan SK; Guo B; Zheng MH; Li F; Yuan LQ; Li ZH
    Signal Transduct Target Ther; 2023 Mar; 8(1):98. PubMed ID: 36864020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.